RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kaken Pharmaceutical Co - Stock

Kaken Pharmaceutical Co Employees 2024

Kaken Pharmaceutical Co Employees

1,268

Ticker

4521.T

ISIN

JP3207000005

In 2024, Kaken Pharmaceutical Co employed 1,268 people, a 0% change from the 1,268 number of employees in the previous year.

Kaken Pharmaceutical Co Aktienanalyse

What does Kaken Pharmaceutical Co do?

Kaken Pharmaceutical Co Ltd is a Japanese pharmaceutical company based in Tokyo. The company was founded in 1949 and has since grown continuously to establish itself as a flagship of the Japanese pharmaceutical industry. The company specializes in the production and sale of prescription and over-the-counter drugs. However, it has also heavily focused on research and development of new medications to expand its market share. Kaken Pharmaceutical's business model is to develop and manufacture high-quality products to ensure they meet the needs and requirements of customers. This includes a wide range of medications, ranging from pain relievers and antiallergics to cosmetic products. The company categorizes its products into five different categories: dermatology, pediatrics, oncology, gastroenterology, and orthopedics. Each of these categories specializes in treating and preventing various diseases, conditions, and complaints, offering a wide range of products. Dermatology is one of the key divisions of Kaken Pharmaceutical. The company offers medications for treating skin conditions such as psoriasis, eczema, dermatitis, and acne. One of its most well-known products is the anti-acne medication Isotretinoin. It works by reducing sebum production, thus reducing inflammation and pore blockage. Kaken Pharmaceutical's pediatrics products focus on treating children. Syrups and drops for symptom relief of colds, coughs, fevers, and diarrhea are among the products offered. In this category, Kaken Pharmaceutical also provides medications for treating children with ADHD. Oncology medications are offered by Kaken Pharmaceutical under the name "Kaken Pharma." These products are intended for the treatment of cancer diseases such as lung, breast, and stomach cancer. The company is constantly striving to improve its research and development to make cancer treatment more effective and efficient. The gastroenterology category focuses on treating digestive disorders such as heartburn, reflux, and gastric ulcers. Kaken Pharmaceutical has introduced several products, including drugs that inhibit stomach acid, which are offered in the form of tablets and granules. Orthopedic medications from Kaken Pharmaceutical are used to treat pain and inflammation of the skeletal system, such as relieving joint pain, arthritis, and osteoporosis. The most well-known product is the pain reliever Ibuprofen, which is available for both oral and topical use. In conclusion, Kaken Pharmaceutical Co Ltd is a company committed to meeting the medical and cosmetic needs of customers. Each product is carefully developed and manufactured to ensure the highest quality and effectiveness. With its wide range of products and research efforts, the company is an important player in the global pharmaceutical market. Kaken Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Kaken Pharmaceutical Co's Employee Base

Kaken Pharmaceutical Co's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Kaken Pharmaceutical Co's operational capacity and future potential.

Year-to-Year Comparison

Assessing Kaken Pharmaceutical Co's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Kaken Pharmaceutical Co's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Kaken Pharmaceutical Co’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Kaken Pharmaceutical Co Stock

How many employees does Kaken Pharmaceutical Co have this year?

Kaken Pharmaceutical Co has 1,268 undefined employees this year.

How many employees did Kaken Pharmaceutical Co have compared to the previous year?

Compared to the previous year, Kaken Pharmaceutical Co had 0% more employees.

What impact did the number of employees have on the company Kaken Pharmaceutical Co?

The number of employees has a direct impact on the efficiency and productivity of Kaken Pharmaceutical Co. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Kaken Pharmaceutical Co?

The number of employees can also have an impact on investors of Kaken Pharmaceutical Co, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Kaken Pharmaceutical Co affect the company?

An increase in equity of Kaken Pharmaceutical Co can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Kaken Pharmaceutical Co's equity affect the company?

A reduction in equity of Kaken Pharmaceutical Co can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Kaken Pharmaceutical Co?

Some factors that can influence the equity of Kaken Pharmaceutical Co include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Kaken Pharmaceutical Co so important for investors?

The equity of Kaken Pharmaceutical Co is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Kaken Pharmaceutical Co influence the company?

The number of employees at Kaken Pharmaceutical Co can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Kaken Pharmaceutical Co evolved in recent years?

In recent years, the number of employees at Kaken Pharmaceutical Co has changed by 0.

How many employees does Kaken Pharmaceutical Co currently have?

Kaken Pharmaceutical Co currently has 1,268 undefined employees.

Why is the number of employees important for investors of Kaken Pharmaceutical Co?

The number of employees is important for investors of Kaken Pharmaceutical Co as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Kaken Pharmaceutical Co take to change the number of employees?

To change the number of employees, Kaken Pharmaceutical Co can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Kaken Pharmaceutical Co pay?

Over the past 12 months, Kaken Pharmaceutical Co paid a dividend of 150 JPY . This corresponds to a dividend yield of about 3.95 %. For the coming 12 months, Kaken Pharmaceutical Co is expected to pay a dividend of 155.09 JPY.

What is the dividend yield of Kaken Pharmaceutical Co?

The current dividend yield of Kaken Pharmaceutical Co is 3.95 %.

When does Kaken Pharmaceutical Co pay dividends?

Kaken Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Kaken Pharmaceutical Co?

Kaken Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Kaken Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 155.09 JPY are expected. This corresponds to a dividend yield of 4.09 %.

In which sector is Kaken Pharmaceutical Co located?

Kaken Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kaken Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kaken Pharmaceutical Co from 12/1/2024 amounting to 75 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Kaken Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Kaken Pharmaceutical Co in the year 2023?

In the year 2023, Kaken Pharmaceutical Co distributed 150 JPY as dividends.

In which currency does Kaken Pharmaceutical Co pay out the dividend?

The dividends of Kaken Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kaken Pharmaceutical Co

Our stock analysis for Kaken Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kaken Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.